Fosamax Lawsuits Update: Judge Declares a Mistrial After Bellwether Fosamax Trial Plaintiff Suffers a Heart Attack, Notes Rottenstein Law Group

The first trial to consider claims that Merck hid the alleged bone-weakening, femur-fracturing side effects of Fosamax ended abruptly this week after plaintiff Christina Su, 67, suffered a heart attack, and New Jersey Superior Court Judge Carol E. Higbee declared a mistrial. Su was deemed not fit enough to endure a trial.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fosamax Lawsuits

The Rottenstein Law Group, a Fosamax law firm, will monitor future trials via numerous sources and will provide updates at www.fosamaxlawsuitscenter.com

We wish Ms. Su a speedy recovery and hope that plaintiffs in other Fosamax lawsuits who believe they were injured by the drug will be compensated for their injuries.

New York, NY (PRWEB) March 20, 2013

The first trial to consider claims that Merck hid the alleged bone-weakening, femur-fracturing side effects of Fosamax ended abruptly this week after plaintiff Christina Su, 67, suffered a heart attack, and New Jersey Superior Court Judge Carol E. Higbee declared a mistrial.* Su was deemed not fit enough to endure a trial. The Rottenstein Law Group, a Fosamax law firm, will monitor future trials via numerous sources and will provide updates at http://www.fosamaxlawsuitscenter.com.

The trial of In re: Su v. Merck & Co. (ATL-L-0789-11-MT, Superior Court of New Jersey, Atlantic City) began on Tuesday, March 12.** Merck has announced in securities filings that it faces more than 3,300 lawsuits (including in both state and federal courts) from plaintiffs alleging either femur fractures or jaw death, according to Bloomberg.

“We wish Ms. Su a speedy recovery,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, “and hope that plaintiffs in other Fosamax lawsuits who believe they were injured by the drug will be compensated for their injuries.”

The Rottenstein Law Group represents clients who believe they have been harmed by Fosamax and encourages people to visit this website for more news on trials and comprehensive information about the drug.

Nationwide lawsuits have been divided into two different federal pretrial case consolidations. Cases involving alleged femur fractures are handled in the U.S. District Court for the District of New Jersey (MDL-2243). Lawsuits related to Fosamax’s alleged jaw death side effects are being handled in the U.S. District Court for the Southern District of New York (MDL-1789).

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)

*law360.com/productliability/articles/424731/mistrial-declared-in-merck-s-1st-fosamax-femur-trial
**bloomberg.com/news/2013-03-12/merck-hid-fosamax-s-bone-weakening-risks-lawyer-contends.html

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com